期刊
BIOMOLECULES & THERAPEUTICS
卷 25, 期 4, 页码 367-373出版社
KOREAN SOC APPLIED PHARMACOLOGY
DOI: 10.4062/biomolther.2016.174
关键词
miRNAs; Exosomes; Liver-specific injury; N-acetyl cysteine; Biomarkers
资金
- National Research Foundation of Korea (NRF) - Korea government [2014R1A5A2009242]
- Intramural Fund of the National Institute on Alcoholism and Alcohol Abuse, NIH, USA
- Korean Biomedical Scientist Fellowship Program Award by the Korean Research Institute of Bioscience and Biotechnology
- National Research Foundation of Korea [2014R1A5A2009242] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)
This study was performed to evaluate whether microRNAs (miRNAs) in circulating exosomes may serve as biomarkers of drug induced liver, kidney, or muscle-injury. Quantitative PCR analyses were performed to measure the amounts of liver-specific miRNAs (miR-122, miR-192, and miR-155), kidney-specific miR-146a, or muscle-specific miR-206 in plasma and exosomes from mice treated with liver, kidney or muscle toxicants. The levels of liver-specific miRNAs in circulating plasma and exosomes were elevated in acetaminophen-induced liver injury and returned to basal levels by treatment with antioxidant N-acetyl-cysteine. Circulating miR-146a and miR-206 were increased in cisplatin-induced nephrotoxicity and bupivacaine-induced myotoxicity, respectively. Taken together, these results indicate that circulating plasma and exosomal miRNAs can be used as potential biomarkers specific for drug-induced liver, kidney or muscle injury.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据